scispace - formally typeset
D

Dirk Hellwig

Researcher at University Hospital Regensburg

Publications -  141
Citations -  5020

Dirk Hellwig is an academic researcher from University Hospital Regensburg. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 33, co-authored 128 publications receiving 4593 citations. Previous affiliations of Dirk Hellwig include University of Cologne & University of Regensburg.

Papers
More filters
Journal Article

Comparison of Different Methods for Delineation of 18F-FDG PET–Positive Tissue for Target Volume Definition in Radiotherapy of Patients with Non–Small Cell Lung Cancer

TL;DR: The different techniques of tumor contour definition by (18)F-FDG PET in radiotherapy planning lead to substantially different volumes, especially in patients with inhomogeneous tumors.
Journal ArticleDOI

18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis.

TL;DR: In this retrospective analysis, the information provided by FDG-PET would have contributed to a substantial reduction of the size of radiotherapy portals, particularly for patients with tumor-associated dys- or atelectasis.
Journal ArticleDOI

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.

TL;DR: FDG PET has the potential to improve the detection of lymphadenopathy and the differential diagnosis of pancreatic masses and was superior to CT and US in detection of node metastases.
Journal ArticleDOI

18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?

TL;DR: For mediastinal staging, the choice of an SUV of 2.5 as the threshold is justified because FNR + FPR is minimized, and the resulting high negative predictive value of 96% allows the omission of mediastinoscopy in patients with negative mediastsinal findings on 18F-FDG PET images.